Cartesian Therapeutics Inc
NASDAQ:RNAC

Watchlist Manager
Cartesian Therapeutics Inc Logo
Cartesian Therapeutics Inc
NASDAQ:RNAC
Watchlist
Price: 20.76 USD -0.1% Market Closed
Market Cap: 496m USD
Have any thoughts about
Cartesian Therapeutics Inc?
Write Note

Cartesian Therapeutics Inc
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cartesian Therapeutics Inc
Cash Interest Paid Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash Interest Paid Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
Cartesian Therapeutics Inc
NASDAQ:RNAC
Cash Interest Paid
$611k
CAGR 3-Years
-28%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash Interest Paid
$40.8m
CAGR 3-Years
-10%
CAGR 5-Years
-7%
CAGR 10-Years
21%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Cartesian Therapeutics Inc's Cash Interest Paid?
Cash Interest Paid
611k USD

Based on the financial report for Jun 30, 2024, Cartesian Therapeutics Inc's Cash Interest Paid amounts to 611k USD.

What is Cartesian Therapeutics Inc's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
-13%

Over the last year, the Cash Interest Paid growth was -75%. The average annual Cash Interest Paid growth rates for Cartesian Therapeutics Inc have been -28% over the past three years , -13% over the past five years .

Back to Top